Skip to content

Randomized controlled trial of efficacy and safety of eight-point acupuncture in ovulation promotion in infertility patients with polycystic ovary syndrome

Randomized controlled trial of efficacy and safety of eight-point acupuncture in ovulation promotion in infertility patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000032
Enrollment
Unknown
Registered
2022-06-22
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Sponsors

Xiyuan Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Meet the "diagnostic criteria of polycystic ovary syndrome in 2003" : ? Rare ovulation or anovulation; ? Clinical and/or laboratory tests show signs of hyperandrogenemia (hirsutism, acne, obesity, elevated androgens); ? Polycystic ovary (ultrasound suggested ovarian volume =10cm3, or the number of follicles with a diameter of 2-9mm on the same section =12). In addition, other causes were excluded, such as congenital adrenal hyperplasia, androgen secretory tumor, Cushing's syndrome, etc. (2) The age range is 20 to 40; (3) No organic lesions were found in the genital tract; (4) at least one oviduct is unobstructed after examination; (5) The male semen was normal; (6) Informed consent cooperation.

Exclusion criteria

Exclusion criteria: (1) complicated with serious primary diseases of cardiovascular, liver, kidney and hematopoietic systems; (2) premature ovarian failure, ovarian insensitivity syndrome and other high gonadotropin; (3) abnormal functions of adrenal gland, thyroid gland, diabetes and other endocrine glands; (4) those who have been treated with hormones other than ethinyl estradiol cyproterone/drospione within 3 months.

Design outcomes

Primary

MeasureTime frame
Ovulation rate;

Secondary

MeasureTime frame
Endometrial receptivity;The pregnancy rate;Sex hormone level;

Countries

China

Contacts

Public ContactLuo Ran
dreamerlr@163.com13521894951

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026